Results 241 to 250 of about 9,113,589 (351)

Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease

Alimentary Pharmacology and Therapeutics, 2017
A. Yarur, Vikram S. Kanagala, D. Stein, Frank Czul, M. Quintero, D. Agrawal, Amir C. Patel, Kari Best, C. Fox, K. Idstein, M. Abreu   +10 more
semanticscholar   +1 more source

The Understudied Landscape of Hidradenitis Suppurativa in Asian Skin of Colour Populations

JEADV Clinical Practice, EarlyView.
Anju George
wiley   +1 more source

Epidemiology and the cost burden of hospitalized pediatric‐onset inflammatory bowel disease in China: A national database study

Pediatric Investigation, EarlyView.
This study provides insights into the clinical characteristics and cost burden of pediatric‐onset inflammatory bowel disease (PIBD) and very early onset IBD (VEO‐IBD) in China. Hospitalizations for PIBD, particularly Crohn's disease, are increasing. Guidelines and health insurance policies can help mitigate the cost burden.
Xiaolu Nie, Jing Li, Hui Xu, Fang Hu, Xiaolin Ye, Mengmeng Yu, Guoshuang Feng, Yueping Zeng, Xin Ni, Jie Wu, Xiaoxia Peng, the Futang Research Center of Pediatric Development (FRCPD)   +11 more
wiley   +1 more source

A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease. [PDF]

Neurogastroenterol Motil
Tempia Valenta S, Ventura S, Benuzzi F, Rizzello F, Gionchetti P, De Ronchi D, Atti AR, Agostini A, Filippini N.   +8 more
europepmc   +1 more source

Longstanding Perianal Ulcers

JEADV Clinical Practice, EarlyView.
Narachai Julanon, Thanaphon Anutraungkool, Sirawich Jessadapattarakul, Vincent Piguet   +3 more
wiley   +1 more source

Mirikizumab pharmacokinetics and exposure–response in pediatric patients with moderate‐to‐severe ulcerative colitis

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 474-485, March 2025.
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani, Laiyi Chua, Wendy J. Komocsar, Amy Larkin, Jordan Johns, Xin Zhang   +5 more
wiley   +1 more source

Fistulizing and Stricturing Esophageal Crohn's Disease Requiring Esophagectomy. [PDF]

ACG Case Rep J
Dimopoulos-Verma C, Ott A, Yeoh A, Barakat M, Bingham D, Keyashian K, Barber G.   +6 more
europepmc   +1 more source

Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease

Gut, 2006
S. Zeissig, N. Bürgel, D. Günzel, J. Richter, J. Mankertz, U. Wahnschaffe, A. J. Kroesen, M. Zeitz, M. Fromm, J. Schulzke   +9 more
semanticscholar   +1 more source

Interleukin‐1 receptor type II and inflammatory bowel disease: A Mendelian randomization study

Rheumatology &Autoimmunity, EarlyView.
This Mendelian Randomization study investigated the association between interleukin‐1 receptor type II (IL‐1RII) and inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC) by utilizing the genome‐wide association studies summary statistics.
Qifan Feng, Nan Li, Yawen Lu, Yinqi Long, Yaru Zhang, Kexin Ma, Shengxiao Zhang, Caihong Wang   +7 more
wiley   +1 more source